An order issued by the FDA to a drug sponsor to delay a proposed clinical investigation or to suspend an ongoing investigation. The clinical hold may apply to one or more of the investigations conducted under an investigational new drug application (IND). A clinical hold may be designated as either complete (all clinical work under an IND is affected) or partial (part of the clinical work under an IND is affected).
English Version PDF(3.13MB)
Spanish Version PDF(3.16MB)